Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 501677898

PADI4 Mouse anti-Human, Biotin, Clone: OTI5C10, liquid, TrueMAB™
SDP

Catalog No. 501677898
Encompass_Preferred
Change view
Click to view available options
Quantity:
50 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
50-167-7898 50 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 50-167-7898 Supplier OriGene Supplier No. TA700440
Add to Cart
Add to Cart

Description

Mouse Monoclonal Antibody

Catalyzes the citrullination/deimination of arginine residues of proteins. Citrullinates histone H3 at ′Arg-8′ and/or ′Arg-17′ and histone H4 at ′Arg-3′, which prevents their methylation by CARM1 and HRMT1L2/PRMT1 and represses transcription. Citrullinates EP300/P300 at ′Arg-2142′, which favors its interaction with NCOA2/GRIP1.

Specifications

Antigen PADI4
Classification Monoclonal
Clone OTI5C10
Concentration 0.5 mg/mL
Conjugate Biotin
Formulation PBS with 10mg/ml BSA, 50% glycerol and 0.05% sodium azide
Gene PADI4
Gene Accession No. Q9UM07
Gene Alias PAD, PAD4, PADI5, PDI4, PDI5
Gene Symbols PADI4
Host Species Mouse
Immunogen Full length human recombit protein of human PADI4 produced in HEK293T cell.
Purification Method Affinity Chromatography
Quantity 50 μg
Regulatory Status RUO
Primary or Secondary Primary
Gene ID (Entrez) 23569
Target Species Human
Content And Storage -20° C, Avoid Freeze/Thaw Cycles
Product Type Antibody
Form Liquid
Isotype IgG1
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.